Kia ora
  
Thank you for your request for official information. The reference number
for your request is: H2023033865
  
As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. However, over the holiday period there
are 3 weeks that don’t count as ‘working days’. For Official Information
Act (OIA) requests, the holiday period is 25 December 2022 to 15 January
2023 (inclusive). This affects OIA requests received on or after 27
November 2022. If you'd like to calculate the timeframe, you can use the
Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  
  
If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account. 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.

 
Ngā mihi
 
OIA Services Team
Manatū Hauora | Ministry of Health
M[4]inistry of Health information releases 
 
 

------------------- Original Message -------------------
From: R. Kingi <[FOI #25103 email]>;
Received: Sat Dec 09 2023 15:12:33 GMT+1300 (New Zealand Daylight Time)
To: OIA Requests <[email address]>; OIA <[email address]>;
Subject: Official Information request - Ribosomal frameshifting in pfizer
injectables

Dear Ministry of Health,

Recently there has been publication of an article detailing so called
ribosomal frameshifting in products that incorperate
N1-methylpseudouridine into the modified mRNA, e.g. the pfizer covid
vaccine.

[5]https://aus01.safelinks.protection.outlo...

This concern was raised in 2021 so obviously it is a risk that competent
scientists could flag, however it was largely ignored at the time.

Please detail all internal communications around frameshifting as a
potential risk, or area of reasonable concern. If it was not considered a
potential risk, please detail internal communications that lead to it
being dismissed as a risk, and how that conclusion was drawn.

Yours faithfully,

R. Kingi
 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...
5. https://www.nature.com/articles/s41586-0...

hide quoted sections

Kia ora
Please find attached a letter rearing your request for information

Ngā mihi 

  

OIA Services Team

Manatū Hauora | Ministry of Health

M[1]inistry of Health information releases 
U[2]nite against COVID-19 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/

hide quoted sections